HOME >> BIOLOGY >> NEWS
Sunlight converts common anti-bacterial agent to dioxin

MINNEAPOLIS / ST. PAUL--Sunlight can convert triclosan, a common disinfectant used in anti-bacterial soaps, into a form of dioxin, and this process may produce some of the dioxin found in the environment, according to research at the University of Minnesota. The researchers said that although the dioxin was a relatively benign form, treating wastewater with chlorine could possibly lead to the production of a much more toxic species of dioxin. The study is in press in the Journal of Photochemistry and Photobiology A: Chemistry.

It had already been known that triclosan could be converted to dioxin in the laboratory, and it was also known that sunlight causes triclosan to degrade in the environment. But it had not been known that the natural degradation resulted in dioxin, said researchers Kristopher McNeill, an assistant professor of chemistry, and William Arnold, assistant professor of civil engineering. They discovered that the reaction could occur in Mississippi River water exposed to ultraviolet light.

"This form of dioxin is at least 150,000 times less toxic than the most dangerous form," said McNeill. "But repeated exposure to chlorine, perhaps in water treatment facilities, could chlorinate triclosan. After chlorinated triclosan is discharged from the facility, sunlight could convert it into more toxic dioxins. Such a process could be a source of highly toxic dioxin in the environment."

"This study also shows that the disappearance of a pollutant such as triclosan doesn't necessarily mean an enviromental threat has been removed," said Arnold. "It may just have been converted into another threat."

The researchers began their study after reading numerous environmental studies that reported the presence of pharmaceutical compounds in surface waters around the nation. McNeill and Arnold decided that the logical next step was to examine the natural processes that led to the loss of such materials in the environment. Last year, the U.
'"/>

Contact: Deane Morrison
morri029@umn.edu
612-624-2346
University of Minnesota
14-Apr-2003


Page: 1 2

Related biology news :

1. Sunlight, PCB exposure enhance skin cancer chances
2. How Nature Harvests Sunlight
3. Researchers discover new oceanic bacterial photopigment that converts light into biochemical energy
4. New process converts municipal waste into commodities and fuel
5. Most recent common ancestor of all living humans surprisingly recent
6. Hidden diversity: DNA barcoding reveals a common butterfly is actually 10 different species
7. European common frog found to use novel mating strategy
8. Genetic clues found for common congenital brain disorder
9. Stanford researchers findings may shed light on common, deadly birth defect
10. U-M scientists find common virus in human prostate tissue
11. Scientists suggest framework for epigenetics in common disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
Cached News: